Home | About us | Editorial Board | Search | Ahead of print | Current Issue | Archives | Instructions | Online submissionContact Us   |  Subscribe   |  Advertise   |  Login  Page layout
Wide layoutNarrow layoutFull screen layout
Lung India Official publication of Indian Chest Society  
  Users Online: 578   Home Print this page  Email this page Small font size Default font size Increase font size
This article has been cited by
1Second-line injectable induced ototoxicity in drug resistant tuberculosis: A systematic review of Indian studies
Rohit Sarin,D. Behera,Ashwani Khanna,Vikram Singh,Prashant Narang,T.S. Deepak
Indian Journal of Tuberculosis.2019;66(2)279
[DOI]
2Putting in harm to cure: Drug related adverse events do not affect outcome of patients receiving treatment for multidrug-resistant Tuberculosis. Experience from a tertiary hospital in Italy
Gina Gualano,Paola Mencarini,Maria Musso,Silvia Mosti,Laura Santangelo,Silvia Murachelli,Angela Cannas,Antonino Di Caro,Assunta Navarra,Delia Goletti,Enrico Girardi,Fabrizio Palmieri,Giuseppe Vittorio De Socio
PLOS ONE.2019;14(2)e0212948
[DOI]
3The impact of adverse events on health-related quality of life among patients receiving treatment for drug-resistant tuberculosis in Johannesburg, South Africa
Tembeka Sineke,Denise Evans,Kathryn Schnippel,Heleen van Aswegen,Rebecca Berhanu,Nozipho Musakwa,Elisabet Lönnmark,Lawrence Long,Sydney Rosen
Health and Quality of Life Outcomes.2019;17(1)e0212948
[DOI]
  Feedback 

Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal